Agilent Technologies will acquire Biocare Medical for $950 million in cash, adding more than 300 specialized antibodies and expanding Agilent’s pathology and immunohistochemistry offerings, according to the companies.
A University of Warwick study finds AI cancer detection models may rely on statistical correlations rather than true biomarker signals, raising concerns about reliability in clinical pathology applications.
The FDA has granted Breakthrough Device Designation to PathAI’s PathAssist Derm, an AI-powered tool designed to analyze digital pathology images of skin lesions and assist pathologists in diagnostic review.
The AI companion analyzes up to five years of personal lab data within the company's patient portal to explain test results and identify health trends.
Researchers at JAX and MIT have developed a microneedle patch that samples immune cells from skin within hours, providing a noninvasive alternative to blood draws and biopsies.
